CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Wall Street Analysts Think Immix Biopharma (IMMX) Could Surge 113.58%: Read This Before Placing a Bet

Positive
AI Analysis

Summary

Wall Street analysts have a bullish outlook on Immix Biopharma with a consensus price target suggesting potential upside of 113.58%.

Importance:2/10
Sentiment:
0.50
stock_analysisanalyst_ratingprice_target
Related Companies

Read the original article

Published by yahoo_finance on June 18, 2026 1:55 PM

Read Original